Unlisted
| Company Name | (주)파마리서치바이오 |
| English Name | PHARMARESEARCH BIO Co., Ltd. |
| Business Reg. No. | 1298638951 |
| CEO | 백승걸, 원치엽 (각자대표) |
| Address | 강원도 강릉시 사임당로 641-3 - |
| Industry | 합성의약품 및 기타 완제 의약품 제조업 |
| Industry Code | 212 |
| Established | 20091028 |
| Phone | 031-8039-1401 |
| Website | www.pr-bio.co.kr |
| Regular Employees | 97persons |
| Corp. Reg. No. | 1311110242344 |
Venture Certified
| 벤처투자유형 | 2015-08-10 ~ 2017-08-09 | 20150300320 | 2015-08-10 |
| 벤처투자유형 | 2017-08-10 ~ 2019-08-09 | 20170300468 | 2015-08-10 |
| 벤처투자유형 | 2019-10-16 ~ 2021-10-15 | 20190300959 | 2015-08-10 |
| 벤처투자유형 | 2021-10-16 ~ 2024-10-15 | 20210915010027 | 2015-08-10 |
| 벤처투자유형 | 2024-10-16 ~ 2027-10-15 | 20240924010026 | 2015-08-10 |
Revenue CAGR +35.1%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 261B | 200B | 125B | 106B |
| Operating Profit | 87B | 62B | 25B | 26B |
| Net Profit | 102B | 23B | 74B | 23B |
| Total Assets | 865B | 639B | 589B | 496B |
| Total Liabilities | 437B | 295B | 369B | 355B |
| Total Equity | 429B | 344B | 220B | 141B |
▲ 81.6%
▲ 129.0%
▲ 31.2%
▼ 39.6%
▲ 25.1%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 정상수 | 사내이사 | 이사회 의장 | - |
| 백승걸 | 사내이사 | 경영총괄 | - |
| 원치엽 | 사내이사 | 연구총괄 | - |
| 김창호 | 사내이사 | 생산총괄 | - |
| 유명규 | 미등기 | 공장총괄 | - |
| 정천수 | 감사 | 감사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - |
| NPS Subscribers | 100persons |
| CEO | 백승걸, 원치엽 (각자대표) |
| Est. Avg. Annual Salary | 4,83710K (40310K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | 0persons |
| NPS Join Date | 2010-03-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "강원도 강릉시",
"ceo_name": "백승걸, 원치엽",
"certificate": [
{
"cert_number": "20150300320",
"changes": "",
"disclosure_date": "2015-08-10",
"first_cert_date": "2015-08-10",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2015-08-10 ~ 2017-08-09"
},
{
"cert_number": "20170300468",
"changes": "",
"disclosure_date": "2017-08-24",
"first_cert_date": "2015-08-10",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2017-08-10 ~ 2019-08-09"
},
{
"cert_number": "20190300959",
"changes": "",
"disclosure_date": "2019-10-16",
"first_cert_date": "2015-08-10",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2019-10-16 ~ 2021-10-15"
},
{
"cert_number": "20210915010027",
"changes": "",
"disclosure_date": "2021-09-15",
"first_cert_date": "2015-08-10",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2021-10-16 ~ 2024-10-15"
},
{
"cert_number": "20240924010026",
"changes": "",
"disclosure_date": "2024-09-24",
"first_cert_date": "2015-08-10",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2024-10-16 ~ 2027-10-15"
}
],
"company_name": "㈜파마리서치바이오",
"financials": {
"2022": {
"capital_stock": 2024696000,
"cost_of_sales": 5689483000,
"current_assets": 42911103000,
"current_liabilities": 19576908000,
"gross_profit": 6816502000,
"net_income": 3971019000,
"net_income_bs": 7418259000,
"non_current_assets": 15994370000,
"non_current_liabilities": 17342055000,
"non_operating_expenses": 6002913000,
"non_operating_income": 7465360000,
"operating_profit": 2508572000,
"revenue": 12505985000,
"sga_expenses": 4307930000,
"total_assets": 58905474000,
"total_equity": 21986510000,
"total_liabilities": 36918963000
},
"2023": {
"capital_stock": 2032196000,
"cost_of_sales": 7676092000,
"current_assets": 45184553000,
"current_liabilities": 28398467000,
"gross_profit": 12354549000,
"net_income": 4640320000,
"net_income_bs": 2308349000,
"non_current_assets": 18740400000,
"non_current_liabilities": 1112236000,
"non_operating_expenses": 3457566000,
"non_operating_income": 1874610000,
"operating_profit": 6223276000,
"revenue": 20030641000,
"sga_expenses": 6131273000,
"total_assets": 63924953000,
"total_equity": 34414250000,
"total_liabilities": 29510703000
}
},
"industry": "합성의약품 및 기타 완제 의약품 제조업",
"investment": [
{
"amount": "10,000,000,000",
"changes": "10,000,000,000",
"date": "2024-02-22"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2017-07-20"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2017-06-29"
}
],
"phone": "031-696-****",
"source": "pg_migration"
}{
"address": "강원특별자치도 강릉시 사임당로",
"brno": "129863****",
"cappedWarning": false,
"companyName": "(주)파마리서치바이오",
"estimatedAvgAnnualSalary": 48366672,
"estimatedAvgMonthlySalary": 4030556,
"fetchedAt": "2026-03-05T12:23:55.827Z",
"industryCode": "513311",
"industryName": "의약품 도매업",
"joinDate": "20100301",
"last12MonthsHired": 0,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 0,
"leaveDate": null,
"monthlyPensionAmount": 38290280,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6711882",
"status": "1",
"styleCode": "1",
"subscriberCount": 100,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |